Scoring of treatment-related late effects in prostate cancer

Radiotherapy and Oncology

Volumn 65, Issue 2, 2002, Pages 109-121

  Livsey, Jacqueline E ^a   Routledge, Jacqueline ^a   Burns, Meriel ^a   Swindell, Rick ^a   Davidson, Susan E ^a   Cowan, Richard A ^a   Logue, John P ^a   Wylie, James P ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

LENT SOMA; Prostate cancer; Radiotherapy; UCLA Prostate Cancer Index

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CORRELATION ANALYSIS; HEALTH SURVEY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SYMPTOM; BLADDER DISEASE; COMPUTER ASSISTED RADIOTHERAPY; ENTERITIS; MIDDLE AGED; PROSTATE TUMOR; PSYCHOLOGICAL ASPECT; SEXUAL DYSFUNCTION; SICKNESS IMPACT PROFILE; TIME;

AGED; AGED, 80 AND OVER; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; QUALITY OF LIFE; QUESTIONNAIRES; RADIOTHERAPY, CONFORMAL; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SICKNESS IMPACT PROFILE; TIME FACTORS; URINARY BLADDER DISEASES;

EID: 0036848191     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(02)00286-4     Document Type: Article

References (17)

1. Boersma L.J., van den Brink M., Bruce A.M., et al. Estimation of the incidence of late bladder and rectum complications after high dose (70-78Gy) conformal radiotherapy for prostate cancer, using dose-volume histogram. Int J Radiat Oncol Biol Phys. 41:1998;83-89.
2. Brenner D.J., Hall E.J. Fractionation and protraction for radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys. 43:1999;1095-1101.
3. Cox J.D., Stetz J., Pajak T.F. Toxicity criteria of the Radiation Oncology Group (RTOG) and the European Organisation for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 31:1995;1341-1346.
4. Davidson S.E., Burns M., Routledge J., et al. Short report: a morbidity scoring system for clinical oncology practice: questionnaires produced from the LENT SOMA scoring system. Clin Oncol. 14:2002;68-69.
5. Denekamp J., Bartelink H., Rubin P. Correction for the use of the SOMA/LENT tables. Radiother Oncol. 39:1996;191.
6. Donovan J.L., Frankel S., Faulkner A., Gillatt D., Hamdy F.C. Dilemmas in treating early prostate cancer: the evidence and a questionnaire survey of consultant urologists in the UK. Br Med J. 318:1999;299-300.
7. Fowler J., Chappell R., Ritter M. Is α/β for prostate tumours really low? Int J Radiat Oncol Biol Phys. 50:2001;1021-1031.
8. Franklin C.I.V., Parker C.A., Morton K.M. Late effects of radiation therapy for prostate carcinoma: the patient's perspective of bladder, bowel and sexual morbidity. Australas Radiol. 42:1998;58-65.
9. Hanlon A.L., Schultheiss T.E., Hunt M.A., et al. Chronic rectal bleeding after high dose conformal treatment of prostate cancer warrants modification of existing morbidity scales. Int J Radiat Oncol Biol Phys. 38:1997;59-63.
10. International Commission on Radiation Units and Measurements . ICRU Report No. 50: prescribing, recording and reporting photon beam therapy. 1993;International Commission on Radiation Units and Measurements, Washington, DC.
11. Johnstone P.A., Gray C., Powell C.R. Quality of life in T1-3N0 prostate cancer patients treated with radiation therapy with minimum 10-year follow-up. Int J Radiat Oncol Biol Phys. 46:2000;833-839.
12. Litwin M.S., Hays R.D., Fink A., et al. The UCLA Prostate Cancer Index. Development, reliability and validity of a health related quality of life measure. Med Care. 36:1998;1002-1012.
13. Madalinska J.B., Essink-Bot M.L., de Koning H.J., et al. Health related quality of life effects of radical prostatectomy and primary radiotherapy for screen-detected or clinically diagnosed localised prostate cancer. J Clin Oncol. 19:2001;1619-1628.
14. Murphy M., Johnston C., Whelan P., Rider L., Lloyd S.N. Changing trends in prostatic cancer. Br J Urol. 83:1999;786-791.
15. Pavy J.J., Denekamp J., Letschert J., et al. Late effects toxicity scoring: the SOMA scale. Radiother Oncol. 35:1995;11-15.
16. Smith D.S., Carvalhal G.F., Schneider K., et al. Quality-of-life outcomes for men with prostate carcinoma detected by screening. Cancer. 88:2000;1454-1463.
17. Ware J.E. Jr., Sherbourne C.D. The MOS 36-item short-form health survey (SF-36). Conceptual framework and item selection. Med Care. 30:1992;473-483.